Utility Therapeutics prepares FDA application

After three years of work, Utlity Therapeutics is almost ready to apply to the FDA for approval for one of its two antibiotics.

Photo: Johannes Skov Andersen POL

Utility Therapeutics, which was founded by the same team as Danish biotech company Union Therapeutics, has almost achieved an important goal.

The company reports that it is almost ready to send an application to the US Food and Drug Administration (FDA) for the use of one of its two antibiotic products, which are the backbone of the company's business. Utility Therapeutics expects to send the application in Q4 2021.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs